About this medicine
Azacitidine Injection
As a nucleoside metabolic inhibitor, azacitidine injection is used to treat numerous forms of cancer. It can be used to treat myelodysplastic syndromes, acute myeloid leukaemia, and chronic myelomonocytic leukaemia by inhibiting the proliferation of cancerous cells. Injections of azacitidine are typically delivered intravenously over the period of 4 to 6 weeks. Patients will have seven to ten injections of the medicine over this period. Injections of Azacitidine may cause nausea, vomiting, diarrhoea, exhaustion, fever, and a higher risk of infection. Patients should be constantly watched for any indications of bleeding, since they may face an increased risk of bleeding. Before commencing therapy, it is crucial to examine the potential hazards connected with the use of azacitidine injection, which is a strong medicine that can be particularly helpful in treating some forms of cancer.
Patients with myelodysplastic syndromes-MDS typically receive this medication to treat their disorder, in which there are not enough healthy blood cells produced by the bone marrow.
This information is for general reference only. Please use this medicine only under the guidance of your doctor, and share your prescription with us when you order.
